Alto Neuroscience Inc Sustainability Reports
Alto Neuroscience, Inc. operates as a clinical-stage biopharmaceutical company that leverages a proprietary neurobiology platform to develop personalized and effective treatment options for mental health conditions.
Sector: Manufacturing
Country: United States
Exchange: New York Stock Exchange
FIGI: BBG00WYFS6S4
1 reports from 2023 to 2023
